Medscape Medical NewsAll articles

DTX Studio Clinic 3.0

Nobel Biocare AB • Radiology • 03/28/2023

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

DTX Studio Clinic 3.0 is an AI-driven medical image analyzer that employs supervised machine learning to process intraoral radiographs and highlight potential dental pathologies for dentists. The device aims to enhance diagnostic accuracy by providing concurrent decision support in identifying findings such as caries, bone loss, and root canal deficiencies in patients 15 years and older.

Summary

DTX Studio Clinic 3.0 is a computer-assisted detection (CADe) software designed to aid dentists in analyzing intraoral radiographs, specifically bitewing and periapical images, for patients aged 15 years and older. The device utilizes an AI-powered Focus Area Detection algorithm, based on supervised machine learning, to identify and localize six specific dental findings: caries, calculus, periapical radiolucency, root canal filling deficiency, discrepancy at the margin of an existing restoration, and bone loss. The system functions as a concurrent review tool, presenting detected focus areas as togglable bounding boxes for the dentist's final diagnostic assessment. Performance data indicates that the AI algorithm, when assessed standalone, demonstrated an overall sensitivity of 0.79 and precision of 0.45, with specific sensitivities varying by finding type (e.g., 0.70 for caries, 0.95 for root canal filling deficiency). A clinical performance study involving 30 readers showed that using DTX Studio Clinic 3.0 significantly improved diagnostic performance, with an 8.7% overall increase in the Area Under the Curve (AUC) for detecting dental findings compared to unaided reading. Sensitivity for detecting existing dental findings improved by 22.4% overall with AI assistance, though a mild decrease in image-level specificity (8.7%) was observed.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

DTX Studio Clinic 3.0Computer-assisted detection (CADe)Intraoral radiographsArtificial intelligence (AI)Dental findingsCaries detectionPeriapical radiolucencyRoot canal filling deficiencyBone loss assessmentMachine learning

Device Metadata

Submission Number
K221921
Company
Nobel Biocare AB
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
detection

Relevant Clinical Questions

  • Q1. How does the algorithm's performance vary across different types or resolutions of intraoral radiographic images (e.g., sensor vs. phosphor plates, different brands)?; What is the clinical significance of the 8.7% decrease in image-level specificity with aided reading, and are there strategies to mitigate potential increases in false positives?; How does the AI model differentiate between subtle pathological findings and normal anatomical variations or artifacts, particularly for bone loss and periapical radiolucency?; What was the range of experience levels among the 30 readers in the clinical study, and did the AI's benefit differ significantly based on reader experience?; Are there plans to expand the detectable dental findings or to adapt the algorithm for different patient populations, such as pediatric patients or those with specific systemic conditions affecting oral health?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score10/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(machine learning, algorithm)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials
- Not detected
HBOMHardware Bill of Materials(sensor)
✓ Detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, HBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, SaaSBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
DTX Studio Clinic 3.0 - Nobel Biocare AB | ESL FDA AI Device Intelligence